Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07624409Phase 1Enrolling by invitation
Phase 1, randomised, single-blind trial (2 arms). Primary endpoints: Aerobic Fitness (ml/kg/min oxygen utilization) at day 7, Glucose Curve and 5 more. Started Jul 2026; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07624409.